Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults

NCT00819013 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza A Vaccine: ACAM FLU-A
BIOLOGICAL: Influenza A Vaccine: ACAM FLU-A
BIOLOGICAL: Influenza A Vaccine: ACAM FLU-A
BIOLOGICAL: Saline placebo

Sponsor

Sanofi